Metformin is considered safe to take while breastfeeding. Only a tiny fraction of the drug passes into breast milk, well below the threshold that pharmacologists consider concerning, and multiple studies have found no adverse effects in nursing infants whose mothers took it.
How Much Reaches Your Baby
The standard measure researchers use to evaluate a drug’s safety during breastfeeding is the relative infant dose: the percentage of the mother’s weight-adjusted dose that an infant would receive through milk. Anything under 10% is generally considered acceptable. Metformin falls far below that cutoff.
In one study measuring metformin transfer in breastfeeding women, the average relative infant dose was just 0.28% of the mother’s weight-adjusted dose. A second study found it slightly higher at 0.65%, with a range topping out around 1%. Either way, the exposure is minimal. In several of the infants tested, metformin was completely undetectable in their blood. In the few where it was detectable, the levels were extremely low, roughly 10 to 15% of their mother’s blood levels, measured several hours after a dose.
Effects on Infant Blood Sugar
Because metformin works by lowering blood sugar, the most logical concern is whether a breastfed infant could develop low blood sugar (hypoglycemia). The research consistently shows this doesn’t happen. In one study, blood glucose levels in three nursing infants were checked four hours after a feeding, and all fell within the normal range of 47 to 77 mg/dL. Another study of newborns just 10 to 11 days old, whose mothers were taking metformin, found none of the infants had low blood sugar. Their mothers also reported no adverse reactions of any kind.
Growth and Development Over Time
Short-term blood tests are reassuring, but parents naturally wonder about longer-term effects. The best evidence on this comes from a six-month prospective trial that tracked 111 infants born to mothers taking metformin at an average dose of 2.2 grams per day, which is on the higher end of typical dosing. Researchers followed 61 predominantly breastfed infants and compared them with 50 formula-fed infants from the same group of mothers. Blinded observers found no differences between the two groups at three and six months in height, weight, motor and social development, or rates of illness.
Smaller studies paint a consistent picture. Seven infants between 5 and 25 months old whose mothers were taking metformin were judged healthy, with growth and development on track. Two of those infants also passed standardized developmental screening tests. Three other infants followed from 2 to 14 months showed no detectable adverse effects.
What Doses Have Been Studied
The safety data covers a broad range of doses. Studies have evaluated mothers taking as little as 500 mg twice daily up to 2.55 grams per day. Across that range, infant exposure through milk remained very low and no problems emerged. This means most typical prescribing patterns for type 2 diabetes, gestational diabetes, or PCOS fall within the range that has been directly studied.
Effects on Milk Supply
Some women taking metformin, particularly those with PCOS, wonder whether the drug helps or hurts milk production. The honest answer is that this hasn’t been rigorously studied yet. No systematic research has examined how insulin resistance, PCOS, or metformin itself affects lactation volumes. Anecdotally, some women with PCOS report that metformin supports their ability to breastfeed, but controlled data is lacking. What the evidence does clearly show is that metformin in breast milk does not harm the nursing infant.
Timing Feeds Around Doses
Because the amount of metformin in breast milk is so small overall, there’s no strong medical reason to time your feedings around your doses. That said, the data shows that metformin levels in milk stay relatively steady rather than spiking sharply after a dose. Peak and trough milk concentrations in one study were 0.42 and 0.39 micrograms per milliliter, barely different from each other. This flat pattern means there isn’t really a “bad time” to nurse after taking your medication. You can feed on your normal schedule without worry.
Why It’s Considered Low Risk
Several factors make metformin unusually reassuring compared to other medications during breastfeeding. The drug transfers into milk at low concentrations, with a milk-to-plasma ratio averaging 0.35 to 0.63 depending on the study. It is often undetectable in infant blood entirely. When it is detectable, the levels are a fraction of what would be needed to have any pharmacological effect. No study has documented hypoglycemia, growth problems, developmental delays, or any other adverse outcome in breastfed infants exposed to metformin through milk. The American Academy of Pediatrics considers most prescription medications compatible with breastfeeding and recommends weighing individual risks and benefits, a balance that tilts strongly in metformin’s favor given the available evidence.